Cancer Prevention Research

Papers
(The H4-Index of Cancer Prevention Research is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-07-01 to 2025-07-01.)
ArticleCitations
Acknowledgment to Reviewers39
Reproductive and Hormonal Factors and Thyroid Cancer Risk: Pooled Analysis of Prospective Cohort Studies in the Asia Cohort Consortium35
Prediction Models for Gastric Cancer Risk in the General Population: A Systematic Review35
Weight Loss During Intrauterine Progestin Treatment for Obesity-associated Atypical Hyperplasia and Early-Stage Cancer of The Endometrium35
Evaluating Intermittent Dosing of Aspirin for Colorectal Cancer Chemoprevention34
One Barrier to Colorectal Cancer Screening Eliminated: On to the Next22
Comparing Breast Cancer and Cardiovascular Disease Risk and Use of Chemoprevention and Statins among Women with High-risk Breast Lesions20
Patient and Provider Web-Based Decision Support for Breast Cancer Chemoprevention: A Randomized Controlled Trial20
Fenretinide in Young Women at Genetic or Familial Risk of Breast Cancer: A Placebo-Controlled Biomarker Trial20
Endoscopic Screening and Risk of Colorectal Cancer according to Type 2 Diabetes Status19
Passing the Torch forward: Moving beyond EGFR Inhibition in NMIBC Prevention19
Risk Stratification for Early-onset Colorectal Cancer Screening: Are We Ready for Implementation?17
Strategies to Identify and Recruit Women at High Risk for Breast Cancer to a Randomized Controlled Trial of Web-based Decision Support Tools17
Editors’ Selections from Relevant Scientific Publications17
Knowledge Mediates the Effects of Game Changers for Cervical Cancer Prevention (GC-CCP) Intervention on Increased VIA Screening Advocacy in Uganda16
Incident Cancer Risk and Signatures Among Older MUTYH Carriers: Analysis of Population-Based and Genomic Cohorts15
Rutgers Cancer Institute of New Jersey's Community Outreach and Engagement Approach to Cancer Prevention15
Retraction: Carnosol, a Constituent of Zyflamend, Inhibits Aryl Hydrocarbon Receptor-Mediated Activation of CYP1A1 and CYP1B1 Transcription and Mutagenesis15
0.167160987854